Abstract
ECMO (Extracorporeal membrane oxygenation) can be used in patients with cardiogenic shock as a bridge to recovery, successful ventricular assist device placement or transplant. There is evidence of increased 30 day survival with ECMO for cardiogenic shock secondary to acute myocardial infarction, fulminant myocarditis and other causes of shock. The purpose of this study was to determine the trends in mortality and differences in demographics in patients using ECMO for cardiogenic shock.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Paper Title
Journal
Date
